Correvio Pharma Corp. Unamortized Debt Issuance Expense
Correvio Pharma Corp. had Unamortized Debt Issuance Expense of $609.00 thousand as of 2016-12-31, per its 40-F filed 2017-03-29.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:UnamortizedDebtIssuanceExpense · last filed 2017-03-29
- 2016-12-31: Unamortized Debt Issuance Expense $609.00K.
- 2015-12-31: Unamortized Debt Issuance Expense $402.00K.
| Period end | Unamortized Debt Issuance Expense |
|---|---|
| 2016-12-31 | $609.00K 40-F · filed 2017-03-29 |
| 2015-12-31 | $402.00K 40-F · filed 2017-03-29 |